|

Dietary Intervention Study on Liver Health in Young Adults

RECRUITINGN/ASponsored by Hochschule Campus Wien (University of Applied Sciences Campus Vienna)
Actively Recruiting
PhaseN/A
SponsorHochschule Campus Wien (University of Applied Sciences Campus Vienna)
Started2026-08-31
Est. completion2026-11
Eligibility
Age20 Years – 30 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07786831

Summary

This prospective randomized dietary intervention study investigates the effects of two dietary approaches on liver health in young adults over a 12-week period. Participants will be randomly assigned to either a Mediterranean diet intervention or a healthy diet based on general dietary recommendations. Liver health will be assessed using the Ultrasound-Guided Attenuation Parameter (UGAP), together with laboratory parameters, body composition measurements, and anthropometric assessments. Measurements will be performed at baseline, after 6 weeks, and after 12 weeks. The study aims to evaluate changes in liver fat and related metabolic parameters over time and to investigate associations between UGAP measurements, laboratory parameters, and body composition.

Eligibility

Age: 20 Years – 30 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 20 to 30 years
* Currently enrolled as a student
* Body mass index (BMI) less than or equal to 29 kg/m\^2
* Willingness to attend all three study visits at baseline, Week 6, and Week 12
* Willingness to follow the assigned dietary intervention throughout the 12-week study period
* Ability to understand the study information and provide written informed consent

Exclusion Criteria:

* Known acute or chronic liver disease, including non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD)
* Acute hepatitis
* History of liver transplantation
* Excessive alcohol consumption
* Heart failure or ascites
* Electronic or implanted medical devices that contraindicate bioelectrical impedance analysis (BIA), such as a cardiac pacemaker
* Pregnancy
* Regular use of medications other than oral contraceptives, including medications with potential hepatotoxic effects
* Extreme dietary patterns or use of dietary supplements that may interfere with study outcomes
* Unwillingness to follow the assigned dietary intervention or comply with standardized measurement conditions
* Inability to provide informed consent

Conditions2

Liver DiseaseLiver Health

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.